The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  New England Journal of Medicine

• Publication date

  1994-11-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199411243312101PMID 7969278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mumps vaccination and meningitis.

  1993cited by this paper
• INFECTIOUS DISEASES Mumps vaccination and meningitis

  1993cited by this paper
• Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients

  1993cited by this paper
• Decline of mumps antibodies in Type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of Type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland

  1993cited by this paper
• Changing epidemiology of measles in Hong Kong from 1961 to 1990--impact of a measles vaccination program.

  1992cited by this paper
• The Measles Outbreak in Chikuhou District, Fukuoka, Japan, 1990: Correlation between Herd Immunity Level and Outbreak Size

  1992cited by this paper
• Monitoring progress toward US preschool immunization goals.

  1992cited by this paper
• The ricochet of magic bullets: summary of the Institute of Medicine Report, Adverse Effects of Pertussis and Rubella Vaccines.

  1992cited by this paper
• Persistence of measles antibody after revaccination.

  1992cited by this paper
• Measles, mumps, and rubella vaccine: time for a two stage policy?

  1992cited by this paper
• Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland.

  1991cited by this paper
• Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population.

  1990cited by this paper
• Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children.

  1989cited by this paper
• Rubella immunity and morbidity: effects of vaccination in Finland.

  1988cited by this paper
• Geographic Patterns of Childhood Insulin-Dependent Diabetes Mellitus

  1988cited by this paper
• Measles virus in the cerebrospinal fluid in postvaccination immunosuppressive measles encephalopathy

  1987cited by this paper
• Safe immunization of allergic children against measles, mumps, and rubella.

  1987cited by this paper
• RAPID EFFECT ON ENDEMIC MEASLES, MUMPS, AND RUBELLA OF NATIONWIDE VACCINATION PROGRAMME IN FINLAND

  1986cited by this paper
• Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins.

  1986cited by this paper
• High measles mortality in infancy related to intensity of exposure.

  1986cited by this paper
• Incidence of congenital rubella syndrome in Japan (1965-1985). A nationwide survey of the number of deaf children with history of maternal rubella attending special schools for the deaf in Japan.

  1986cited by this paper
• Persistent rubella virus infection associated with chronic arthritis in children.

  1985cited by this paper
• Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children.

  1984cited by this paper
• Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience.

  1983cited by this paper
• Vaccination against rubella and measles: quantitative investigations of different policies

  1983cited by this paper
• Antibody response following measles-mumps-rubella vaccine under conditions of customary use.

  1983cited by this paper
• Measles and rubella in the United States.

  1983cited by this paper
• CHRONIC ENCEPHALOMYELITIS WITH SPECIFIC INCREASE IN INTRATHECAL MUMPS ANTIBODIES

  1982cited by this paper
• Thrombocytopenic purpura after measles vaccination.

  1981cited by this paper
• Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination.

  1981cited by this paper
• Clinical and Laboratory Studies of Combined Live Measles, Mumps, and Rubella Vaccines Using the RA 27/3 Rubella Virus

  1980cited by this paper
• Persistence of Antibody in Human Subjects for 7 to 10 Years following Administration of Combined Live Attenuated Measles, Mumps, and Rubella Virus Vaccines

  1980cited by this paper
• Hemolysis‐in‐gel test in immunity surveys and diagnosis of rubella

  1979cited by this paper
• Additional evidence against measles vaccine administration to infants less than 12 months of age: altered immune response following active/passive immunization.

  1979cited by this paper
• Rubella vaccination and thrombocytopenia.

  1974cited by this paper
• Mumps vaccination in the Finnish defense forces.

  1968cited by this paper
• Purpura in congenital and acquired rubella.

  1965cited by this paper
• POSTRUBELLA THROMBOCYTOPENIC PURPURA.

  1965cited by this paper
• Perceptive deafness in connectionwith mumps. A study of 298 servicemen suffering from mumps.

  1962cited by this paper
• Thrombocytopenic purpura in measles.

  1956cited by this paper

• Assessment of Cattle Vaccine Effectiveness and Associated Constraints in Selected Districts of Kilteawlaelo and Mekelle, Tigray, Northern Ethiopia

  2025cites this paper
• Adjuvant-Induced Autoimmune Syndrome: A Bibliometric Analysis

  2024cites this paper
• Autoantibodies in COVID‐19 and Other Viral Diseases: Molecular, Cellular, and Clinical Perspectives

  2024cites this paper
• Vaccines and Autoimmunity—From Side Effects to ASIA Syndrome

  2023cites this paper
• Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) - past, present, and future implications.

  2023cites this paper
• Impact of pandemics and disruptions to vaccination on infectious diseases epidemiology past and present

  2023cites this paper
• Titerphilia - The Irresistible Urge to Measure Postimmunization Antibody Values.

  2022cites this paper
• Pediatric Lower Respiratory Tract Infections: Imaging Guidelines and Recommendations.

  2022cites this paper
• Measles: Global Indicators and Progress on the road for Achieving and Sustaining Virus Eradication: A Review

  2022cites this paper
• Immunological Memory and Affinity Maturation After Vaccination in Patients With Propionic Acidemia

  2022cites this paper
• Evaluation of the Safety and Immunogenicity of M-M-RII (Combination Measles-mumps-rubella Vaccine)

  2021cites this paper
• The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study

  2021cites this paper
• Response to Vaccination against Mumps in Medical Students: Two Doses Are Needed

  2021influential citation
• Rubella, German Measles

  2021cites this paper
• Etiology of Infectious Diseases in Acutely Ill Children at a Pediatric Hospital in Finland

  2021cites this paper
• A Relapsing Immune Thrombocytopenia Case in a Patient Following COVID-19 Vaccination

  2021cites this paper
• Measles–Mumps–Rubella Vaccine

  2021cites this paper
• In-vitro and in-vivo study of the interference between Rift Valley fever virus (clone 13) and Sheeppox/Lumpy Skin disease viruses

  2021cites this paper
• Pediatric patient with a rash

  2020cites this paper
• On the epidemiology, clinical presentation and transmission of respiratory viral infections

  2020cites this paper
• Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine

  2020influential citation
• Classification of measles cases from 2014 to 2018: Implications for progress towards measles elimination in China.

  2020cites this paper
• Kingella kingae

  2020cites this paper
• Inducible IFN-γ Expression for MHC-I Upregulation in Devil Facial Tumor Cells

  2019cites this paper
• Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections

  2019cites this paper
• Green Prescriptions and Their Co-Benefits: Integrative Strategies for Public and Environmental Health

  2019cites this paper
• Deciphering the ontogeny of unmutated and mutated subsets of Chronic Lymphocytic Leukemia

  2019cites this paper
• 40 – Mumps Vaccines

  2018cites this paper
• Refusal of Vaccination: A Test to Balance Societal and Individual Interests

  2018cites this paper
• 53 – Rubella Vaccines

  2018cites this paper
• Public Health Crisis in War and Conflict - Health Security in Aggregate.

  2017cites this paper
• Paediatric Virology : A rapidly increasing educational challenge ( Review )

  2017cites this paper
• Prevalence of Varizella-Zoster Virus Infection among Encephalitis Study Groups World Wide

  2017cites this paper
• Inferring rubella outbreak risk from seroprevalence data in Belgium.

  2016cites this paper
• IMMUNE THROMBOCYTOPENIA; FOLLOWING SEASONAL FLU VACCINE AND NONSTEROIDAL ANTI-INFLAMMATORY DRUG USE

  2016cites this paper
• Measles Outbreak Among Previously Immunized Healthcare Workers, the Netherlands, 2014.

  2016cites this paper
• Safety and Immunogenicity of M-M-RII (Combination Measles–Mumps–Rubella Vaccine) in Clinical Trials of Healthy Children Conducted Between 1988 and 2009

  2016cites this paper
• Paediatric Virology: A rapidly increasing educational challenge

  2016cites this paper
• Viral etiology of mumps-like illnesses in suspected mumps cases reported in Catalonia, Spain

  2015cites this paper
• [Etiology, clinical presentation and outcome of severe viral acute childhood encephalitis (ECOVE study)].

  2015cites this paper
• Vaccinations and Type 1 Diabetes

  2015cites this paper
• Live Attenuated Measles Mumps and Rubella Vaccines: An Over View

  2015cites this paper
• M-M-R(®)II manufactured using recombinant human albumin (rHA) and M-M-R(®)II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children.

  2015cites this paper
• Outbreak report: nosocomial transmission of measles through an unvaccinated healthcare worker-implications for public health.

  2014cites this paper
• A questionnaire-based survey on the uptake and use of cattle vaccines in the UK

  2014cites this paper
• Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage.

  2014cites this paper
• Introducing combined measles, mumps and rubella vaccine in Chandigarh, India: Issues and concerns!

  2014cites this paper
• Attrition in a 30-year follow-up of a perinatal birth risk cohort: factors change with age

  2014cites this paper
• Serological assessment of measles–rubella vaccination catch‐up campaign among university students

  2014cites this paper
• 22 – Mumps vaccine

  2013cites this paper
• Quick Assessment: Maßnahmen zur Erhöhung der MMR-Durchimpfungsrate – Übersicht aus Literatur und Länderrecherchen

  2013cites this paper
• [Effects of the MMR vaccination on the epidemiology of mumps in Germany].

  2013cites this paper
• Seroprevalence of rubella among women of childbearing age in Algeria. Is there a need for a rubella vaccination?

  2013cites this paper
• Effekte der Masern-Mumps-Röteln (MMR)-Impfung auf die Epidemiologie von Mumps in Deutschland

  2013cites this paper
• Should the UK introduce compulsory vaccination?

  2013cites this paper
• Changes in Infectious Disease Mortality in Children During the Past Three Decades

  2013cites this paper
• Rapid Detection of Viruses Using Loop-Mediated Isothermal Amplification (LAMP): A Review

  2013cites this paper
• Waning antibody levels and avidity: implications for MMR vaccine-induced protection.

  2012influential citation
• Séroprévalence de la rubéole chez la femme en âge de procréer deux ans après l’introduction de la vaccination en Tunisie

  2012cites this paper
• Mumps: burden of disease in France.

  2012cites this paper
• A Rare Event: A Measles Outbreak in a Population With High 2-Dose Measles Vaccine Coverage

  2012cites this paper
• umps : Burden of disease in France

  2012cites this paper
• Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine Manufactured With Recombinant Human Albumin

  2012cites this paper
• Morbidity and Mortality Weekly Report

  2012cites this paper
• Ongoing mumps outbreak in Novi Sad, the autonomous province of Vojvodina, Serbia, January to April 2012.

  2012cites this paper
• Measles-Mumps-Rubella Vaccination Day-to-Day Reactogenicity and the Healthy Vaccinee Effect of

  2012cites this paper
• Infections in pediatrics: old and new diseases.

  2012cites this paper
• Childhood vaccinations in Croatia

  2012cites this paper
• Rare Event : A Measles Outbreak in a Population With High 2-Dose Measles Vaccine Coverage

  2012cites this paper
• Immunogenicity and Safety of Two Tetravalent (Measles, Mumps, Rubella, Varicella) Vaccines Coadministered With Hepatitis A and Pneumococcal Conjugate Vaccines to Children Twelve to Fourteen Months of Age

  2012cites this paper
• [Rubella seroprevalence in Tunisian childbearing women two years after vaccination program introduction].

  2012cites this paper
• MMR vaccine effectiveness in an outbreak that involved day-care and primary schools.

  2011cites this paper
• Rubella seroprevalence among healthy individuals in Izmir, Turkey

  2011cites this paper
• Immune response to second dose of MMR vaccine in Indian children

  2011cites this paper
• Infections of the central nervous system of suspected viral origin: A collaborative study from Finland

  2011cites this paper
• The History of Measles Virus and the Development and Utilization of Measles Virus Vaccines

  2011cites this paper
• History of vaccine development

  2011cites this paper
• Rekomendacje zespołu ekspertów dotyczące stosowania dwudawkowego schematu szczepień przeciw ospie wietrznej

  2010cites this paper
• Mumps Orchitis in the Post-Vaccine Era (1967-2009): A Single-Center Series of 67 Patients and Review of Clinical Outcome and Trends

  2010cites this paper
• [Epidemiology of hospitalizations caused by rubella in the general population in Spain (1997-2006)].

  2010cites this paper
• Immunoprophylaxis of Viral Diseases

  2010cites this paper
• Antibody dynamics after tick-borne encephalitis and measles-mumps-rubella vaccination in children post early thymectomy.

  2010cites this paper
• Rubella: serosusceptibility among Egyptian females in late childhood and childbearing period.

  2010cites this paper
• Improving Health through Elimination and Eradication of Vaccine Preventable Diseases

  2010cites this paper
• Guidelines for the Prevention and Control of Mumps Outbreaks in Canada.

  2010cites this paper
• The multi-systemic nature of diabetes mellitus: Genotype or phenotype?

  2010cites this paper
• MMR vaccination and disease elimination: the Finnish experience

  2010cites this paper
• Surveillance and Control of Rubella in the Republic of Korea From 2001 to 2009: The Necessity for Enhanced Surveillance to Monitor Congenital Rubella Syndrome

  2010cites this paper
• Immunization of liver and renal transplant recipients: a seroepidemiological and sociodemographic survey

  2009cites this paper
• Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro®) and a varicella vaccine (VARIVAX®) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial

  2009cites this paper
• Differential diagnosis of acute central nervous system infections in children using modern microbiological methods

  2009cites this paper
• Sarampión. Riesgo de reemergencia

  2009cites this paper
• Humoral immunogenicity to measles, rubella, and varicella-zoster vaccines in biliary atresia children.

  2009cites this paper
• Human herpesvirus 6 in multiple sclerosis and encephalitis

  2009cites this paper
• Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.

  2009cites this paper
• Elimination of endemic measles transmission in Australia.

  2009cites this paper
• Varicella vaccination in Europe – taking the practical approach

  2009cites this paper
• The role of vaccines in elimination and global eradication of measles: A review of literature

  2009cites this paper
• The epidemiology of mumps in Italy.

  2008cites this paper
• The incidence of acute encephalitis syndrome in Western industrialised and tropical countries

  2008cites this paper